Recon: J&J halts Varipulse heart device launch following stroke reports; Seikagaku’s painkiller may require narrower indication and REMS
ReconJason Scott
Adverse eventsBiologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyREMSUnited States